Journal
PHARMACEUTICALS
Volume 14, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/ph14060491
Keywords
epigenetics; non-coding RNA; DNA methylation; histone modification; nephrotoxicity
Categories
Funding
- ANID-FAPESP [19/13250-1]
- FONDECYT [1171765]
- Programa de Formacion de Investigadores Postdoctorales, VRIP, Universidad de La Frontera, Temuco, Chile [VRIP 21001]
Ask authors/readers for more resources
Cisplatin, an antineoplastic drug, is most notably known for its nephrotoxicity among various side effects. Recent research shows that epigenetic regulation plays a key role in cisplatin-induced nephrotoxicity by altering different signaling pathways leading to cell death. Despite the ongoing development in this field, it offers new strategies for the diagnosis and treatment of diseases.
Cisplatin is an antineoplastic drug used for the treatment of many solid tumors. Among its various side effects, nephrotoxicity is the most detrimental. In recent years, epigenetic regulation has emerged as a modulatory mechanism of cisplatin-induced nephrotoxicity, involving non-coding RNAs, DNA methylation and histone modifications. These epigenetic marks alter different signaling pathways leading to damage and cell death. In this review, we describe how different epigenetic modifications alter different pathways leading to cell death by apoptosis, autophagy, necroptosis, among others. The study of epigenetic regulation is still under development, and much research remains to fully determine the epigenetic mechanisms underlying cell death, which will allow leading new strategies for the diagnosis and therapy of this disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available